Cargando…
Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit
AIMS/INTRODUCTION: We compared the results of testing for glutamic acid decarboxylase antibodies (GADAb) using a radioimmunoassay (RIA) and an enzyme‐linked immunosorbent assay (ELISA) in individuals with childhood‐onset type 1 diabetes mellitus. MATERIALS AND METHODS: Serum specimens were collected...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232289/ https://www.ncbi.nlm.nih.gov/pubmed/31756289 http://dx.doi.org/10.1111/jdi.13184 |
_version_ | 1783535353458589696 |
---|---|
author | Sugihara, Shigetaka Yokota, Ichiro Mukai, Tokuo Mochizuki, Takahiro Nakayama, Masashi Tachikawa, Emiko Kawada, Yasumasa Minamitani, Kinship Kikuchi, Nobuyuki Urakami, Tatsuhiko Kawamura, Tomoyuki Kawasaki, Eiji Kikuchi, Toru Amemiya, Shin |
author_facet | Sugihara, Shigetaka Yokota, Ichiro Mukai, Tokuo Mochizuki, Takahiro Nakayama, Masashi Tachikawa, Emiko Kawada, Yasumasa Minamitani, Kinship Kikuchi, Nobuyuki Urakami, Tatsuhiko Kawamura, Tomoyuki Kawasaki, Eiji Kikuchi, Toru Amemiya, Shin |
author_sort | Sugihara, Shigetaka |
collection | PubMed |
description | AIMS/INTRODUCTION: We compared the results of testing for glutamic acid decarboxylase antibodies (GADAb) using a radioimmunoassay (RIA) and an enzyme‐linked immunosorbent assay (ELISA) in individuals with childhood‐onset type 1 diabetes mellitus. MATERIALS AND METHODS: Serum specimens were collected from 1,024 Japanese children (426 boys and 598 girls) in 2013. The median age at diagnosis was 7 years (0–18 years). The blood specimens were obtained at a median age of 13 years (2–22 years). RESULTS: Among the 628 children whose serum specimens were collected within 5 years after diagnosis, the rate of GADAb positivity was 47.9% using RIA and 69.4% using ELISA. The participants were divided into four groups according to their RIA and ELISA results for GADAb as follows: group I (RIA+/ELISA+), group II (RIA+/ELISA−), group III (RIA−/ELISA+) and group IV (RIA−/ELISA−). The clinical and genetic characteristics of group I and group III were quite similar in terms of age at diagnosis, male/female ratio, relatively high positive rates for both autoantibody to protein tyrosine phosphatase IA‐2 and autoantibody to the cation efflux transporter zinc transporter 8, and human leukocyte antigen genotype. Group II contained just five patients, and was characterized by a younger age at diagnosis, low positive rates for both autoantibody to protein tyrosine phosphatase IA‐2 and autoantibody to the cation efflux transporter zinc transporter 8, and a unique human leukocyte antigen genotype. If the positive rates of either autoantibody to protein tyrosine phosphatase IA‐2 or autoantibody to the cation efflux transporter zinc transporter 8 or both were added to the GADAb results using RIA, the percentage of autoimmune type 1 diabetes increased from 47.9% to 78.5%. CONCLUSIONS: The diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes increased when GADAb results were obtained using a new ELISA method, compared with a previously utilized RIA method. |
format | Online Article Text |
id | pubmed-7232289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72322892020-05-19 Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit Sugihara, Shigetaka Yokota, Ichiro Mukai, Tokuo Mochizuki, Takahiro Nakayama, Masashi Tachikawa, Emiko Kawada, Yasumasa Minamitani, Kinship Kikuchi, Nobuyuki Urakami, Tatsuhiko Kawamura, Tomoyuki Kawasaki, Eiji Kikuchi, Toru Amemiya, Shin J Diabetes Investig Articles AIMS/INTRODUCTION: We compared the results of testing for glutamic acid decarboxylase antibodies (GADAb) using a radioimmunoassay (RIA) and an enzyme‐linked immunosorbent assay (ELISA) in individuals with childhood‐onset type 1 diabetes mellitus. MATERIALS AND METHODS: Serum specimens were collected from 1,024 Japanese children (426 boys and 598 girls) in 2013. The median age at diagnosis was 7 years (0–18 years). The blood specimens were obtained at a median age of 13 years (2–22 years). RESULTS: Among the 628 children whose serum specimens were collected within 5 years after diagnosis, the rate of GADAb positivity was 47.9% using RIA and 69.4% using ELISA. The participants were divided into four groups according to their RIA and ELISA results for GADAb as follows: group I (RIA+/ELISA+), group II (RIA+/ELISA−), group III (RIA−/ELISA+) and group IV (RIA−/ELISA−). The clinical and genetic characteristics of group I and group III were quite similar in terms of age at diagnosis, male/female ratio, relatively high positive rates for both autoantibody to protein tyrosine phosphatase IA‐2 and autoantibody to the cation efflux transporter zinc transporter 8, and human leukocyte antigen genotype. Group II contained just five patients, and was characterized by a younger age at diagnosis, low positive rates for both autoantibody to protein tyrosine phosphatase IA‐2 and autoantibody to the cation efflux transporter zinc transporter 8, and a unique human leukocyte antigen genotype. If the positive rates of either autoantibody to protein tyrosine phosphatase IA‐2 or autoantibody to the cation efflux transporter zinc transporter 8 or both were added to the GADAb results using RIA, the percentage of autoimmune type 1 diabetes increased from 47.9% to 78.5%. CONCLUSIONS: The diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes increased when GADAb results were obtained using a new ELISA method, compared with a previously utilized RIA method. John Wiley and Sons Inc. 2019-12-24 2020-05 /pmc/articles/PMC7232289/ /pubmed/31756289 http://dx.doi.org/10.1111/jdi.13184 Text en © 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Articles Sugihara, Shigetaka Yokota, Ichiro Mukai, Tokuo Mochizuki, Takahiro Nakayama, Masashi Tachikawa, Emiko Kawada, Yasumasa Minamitani, Kinship Kikuchi, Nobuyuki Urakami, Tatsuhiko Kawamura, Tomoyuki Kawasaki, Eiji Kikuchi, Toru Amemiya, Shin Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit |
title | Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit |
title_full | Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit |
title_fullStr | Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit |
title_full_unstemmed | Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit |
title_short | Increased diagnosis of autoimmune childhood‐onset Japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit |
title_sort | increased diagnosis of autoimmune childhood‐onset japanese type 1 diabetes using a new glutamic acid decarboxylase antibody enzyme‐linked immunosorbent assay kit, compared with a previously used glutamic acid decarboxylase antibody radioimmunoassay kit |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232289/ https://www.ncbi.nlm.nih.gov/pubmed/31756289 http://dx.doi.org/10.1111/jdi.13184 |
work_keys_str_mv | AT sugiharashigetaka increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT yokotaichiro increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT mukaitokuo increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT mochizukitakahiro increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT nakayamamasashi increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT tachikawaemiko increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT kawadayasumasa increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT minamitanikinship increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT kikuchinobuyuki increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT urakamitatsuhiko increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT kawamuratomoyuki increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT kawasakieiji increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT kikuchitoru increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT amemiyashin increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit AT increaseddiagnosisofautoimmunechildhoodonsetjapanesetype1diabetesusinganewglutamicaciddecarboxylaseantibodyenzymelinkedimmunosorbentassaykitcomparedwithapreviouslyusedglutamicaciddecarboxylaseantibodyradioimmunoassaykit |